DSN
NVO

D. Scott Neal’s Novo Nordisk NVO Stock Holding History

D. Scott Neal’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,210
Closed -$222K – 59
2025
Q2 		$222K Sell
3,210
-40
-1% -$2.72K 0.11% 53
2025
Q1 		$226K Hold
3,250
– – 0.13% 49
2024
Q4 		$280K Hold
3,250
– – 0.15% 47
2024
Q3 		$387K Sell
3,250
-30
-0.9% -$4K 0.2% 40
2024
Q2 		$468K Hold
3,280
– – 0.26% 38
2024
Q1 		$424K Buy
3,280
+70
+2% +$8.33K 0.28% 44
2023
Q4 		$332K Sell
3,210
-46
-1% -$4.55K 0.3% 43
2023
Q3 		$296K Hold
3,256
– – 0.25% 47
2023
Q2 		$263K Hold
3,256
– – 0.2% 55
2023
Q1 		$259K Hold
3,256
– – 0.14% 56
2022
Q4 		$220K Buy
+3,256
New +$191K 0.11% 56

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D. Scott Neal's NVO Position: Q3 2025 in Review

D. Scott Neal sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 3,210 shares — an estimated $222K sold.

D. Scott Neal first reported a position in NVO in Q4 2022 and held it in 11 quarters. The position peaked at $468K in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • D. Scott Neal reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • D. Scott Neal sold 3,210 Novo Nordisk shares in Q3 2025, an estimated $222K.
  • D. Scott Neal first reported a position in Novo Nordisk in Q4 2022 and held it in 11 quarters.
  • D. Scott Neal's Novo Nordisk position peaked at $468K in Q2 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on D. Scott Neal's 13F filing for Q3 2025, filed 28 Oct 2025.